References
- Cheson BD, Sorensen JM, Vena DA et al. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the group C protocol mechanism of the National Cancer Institute: a report of 979 patients. J Clin Oncol 1998; 16: 3007–3015.
- Zuzel M, Cawley JC. The biology of hairy cells. Best Pract Res Clin Haematol 2003; 16: 1–13.
- Flandrin G, Sigaux F, Castaigne S et al. Hairy cell leukemia: study of the development of 211 cases. Presse Med 1984; 13: 2795–2799.
- Lembersky BC, Ratain MJ, Golomb HM. Skeletal complications in hairy cell leukemia: diagnosis and therapy. J Clin Oncol 1988; 6: 1280–1284.
- Dorsey JK, Penick GD. The association of hairy cell leukemia with unusual immunologic disorders. Arch Intern Med 1982; 142: 902–903.
- Goodman GR, Burian C, Koziol JA et al. Extended follow-up of patients with hairy cell leukemia after treatment with cladribine. J Clin Oncol 2003; 21: 891–896.
- Domingo A, Crespo N, Fernandez de Sevilla A et al. Hairy cell leukemia and autoimmune hemolytic anemia. Leukemia 1992; 6: 606–607.
- Robak T, Blasiriska-Morawiec M, Krykowski E et al. Autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia treated with 2-chlorodeoxyadenosine (cladribine). Eur J Haematol 1997; 58: 109–113.